Lauren E. Haydu, PhD MPH

Citada per

	Totes	Des de 2019
Citacions	80201	44077
Índex h	67	56
Índex i10	147	137

10000

5000

2500

7500

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320241048 1691 1766 1657 1792 1773 1651 1665 1539 1559 1609 1869 1985 2126 2326 2645 2904 3675 5624 7826 9118 9371 8763 3342

Accés públic

Mostra-ho tot

88 articles

4 articles*

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

John F ThompsonMelanoma Institute AustraliaCorreu electrònic verificat a melanoma.org.au
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalCorreu electrònic verificat a sswahs.nsw.gov.au
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalCorreu electrònic verificat a sydney.edu.au
Alexander M MenziesMelanoma Institute Australia, The University of Sydney, Royal North Shore HospitalCorreu electrònic verificat a sydney.edu.au
Richard KeffordMacquarie UniversityCorreu electrònic verificat a mq.edu.au
Robyn SawMelanoma Institute AustraliaCorreu electrònic verificat a melanoma.org.au
A SpillaneUniversity of SydneyCorreu electrònic verificat a melanoma.org.au
Jonathan StretchMelanoma Institute AustraliaCorreu electrònic verificat a melanoma.org.au
Jeff GershenwaldThe University of Texas MD Anderson Cancer CenterCorreu electrònic verificat a mdanderson.org
Graham MannCollege of Health and Medicine, Australian National UniversityCorreu electrònic verificat a anu.edu.au
Gerald FogartyICON Cancer Centre, Revesby, Sydney NSW.Correu electrònic verificat a Icon.Team
James S WilmottMelanoma Institute Australia, The University of SydneyCorreu electrònic verificat a sydney.edu.au
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer CtrCorreu electrònic verificat a mdanderson.org
Carlino Matteo SMelanoma Institute Australia; Westmead HospitalCorreu electrònic verificat a sydney.edu.au
Jennifer Leigh McQuadeInstructor of Melanoma Medical Oncology, UT MD Anderson Cancer CenterCorreu electrònic verificat a mdanderson.org
Rajmohan MuraliMemorial Sloan Kettering Cancer CenterCorreu electrònic verificat a mskcc.org
Serigne LoMelanoma Institute Australia, The University of SydneyCorreu electrònic verificat a melanoma.org.au
Peter HerseyCorreu electrònic verificat a sydney.edu.au
Helen RizosMacquarie UniversityCorreu electrònic verificat a mq.edu.au
Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLCorreu electrònic verificat a moffitt.org

Segueix

Lauren E. Haydu, PhD MPH

Mayo Clinic

Correu electrònic verificat a mayo.edu

Biostatistician


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Initial sequencing and analysis of the human genome US DOE Joint Genome Institute: Hawkins Trevor 4 Branscomb Elbert 4 Predki ... nature 409 (6822), 860-921, 2001	30561	2001
Finishing the euchromatic sequence of the human genome International Human Genome Sequencing Consortium Nature 431 (7011), 931-945, 2004	5191	2004
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4410	2018
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018	3863	2018
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015	2675	2015
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2582	2018
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2447	2018
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017	2227*	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2156	2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2023	2018
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020	1687	2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1582	2018
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ... Journal of Clinical Oncology 29 (10), 1239-1246, 2011	1270	2011
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016	927	2016
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	826	2018
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018	712	2018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018	710	2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018	707	2018
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma JS Wilmott, GV Long, JR Howle, LE Haydu, RN Sharma, JF Thompson, ... Clinical cancer research 18 (5), 1386-1394, 2012	668	2012
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas T Palomero, L Couronné, H Khiabanian, MY Kim, A Ambesi-Impiombato, ... Nature genetics 46 (2), 166-170, 2014	659	2014

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors